Q amp;A Dr. Jeffrey M. Drazen on drug trial results The editors of 11 top medical journals shook up the staid world of academic publishing this past week when they decided to stop printing results of drug trials that aren't registered in a central database. Globe biotechnology reporter Jeffrey Krasner spoke with Dr. Jeffrey M. Drazen , editor-in-chief of the New England Journal of Medicine, about how the policy should ...